Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma

NCT00587288 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

BIOLOGICAL: Reslizumab
OTHER: Saline

Sponsor

Ception Therapeutics

Collaborators

[object Object]